×
Natera Inventory 2014-2024 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera inventory for the quarter ending September 30, 2024 was
$0.049B
, a
15.8% increase
year-over-year.
Natera inventory for 2023 was
$0.041B
, a
15.12% increase
from 2022.
Natera inventory for 2022 was
$0.035B
, a
31.58% increase
from 2021.
Natera inventory for 2021 was
$0.027B
, a
34.34% increase
from 2020.
View More
Natera Inventory 2014-2024 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera inventory for 2023 was
$0.041B
, a
15.12% increase
from 2022.
Natera inventory for 2022 was
$0.035B
, a
31.58% increase
from 2021.
Natera inventory for 2021 was
$0.027B
, a
34.34% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$88.4B
Cencora (COR)
$45.7B
DiDi Global (DIDIY)
$22B
ICON (ICLR)
$18B
Avantor (AVTR)
$14.7B
Viatris (VTRS)
$13.9B
Revvity (RVTY)
$13.9B
BioMerieux (BMXMF)
$12.6B
CochLear (CHEOY)
$12.1B
Solventum (SOLV)
$11.6B
Medpace Holdings (MEDP)
$10.9B
Doximity (DOCS)
$9.7B
EUROFINS SCIENT (ERFSF)
$9.7B
Charles River Laboratories (CRL)
$9.5B
HealthEquity (HQY)
$8.7B
Sonic Healthcare (SKHHY)
$8.2B
Bausch + Lomb (BLCO)
$6.3B
Amplifon S.p.A (AMFPF)
$5.9B
Organon (OGN)
$4.1B
Sotera Health (SHC)
$3.7B
BrightSpring Health Services (BTSG)
$3B
Surgery Partners (SGRY)
$2.6B
Concentras Parent (CON)
$2.5B
GeneDx Holdings (WGS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2B
PACS (PACS)
$2B
GoodRx Holdings (GDRX)
$1.7B
Teladoc Health (TDOC)
$1.7B